Prof Balram is the Principal Clinical Pharmacologist at National Cancer Center Singapore (NCCS). As one of the leading researchers in pharmacogenomics in Singapore, his research focuses on applying pharmacokinetics (PK) and pharmacodynamics (PD) principles for dose optimization and using pharmacogenomics to understand the inter-individual and inter-ethnic variability in clinical outcomes, especially in Asian ethnic groups. He is also the Director of SingHealth Clinical Pharmacology core platform which offers therapeutic drug monitoring, bioanalytical, pharmacokinetics and genotyping services to local healthcare institutions, pharmaceutical companies and academic research laboratories. Prof Balram has co-authored over 90 publications and is an editorial board member for numerous drug metabolism and pharmacology-based journals. He holds multiple academic appointments at Duke-NUS Graduate Medical School and Nanyang Technological University, Singapore (NTU) and currently serves on advisory committees, grant review boards and research councils at both national and institution levels.